GB Patent

GB0016040D0 — Novel process for preparing crystalline particles

Assigned to Glaxo Group Ltd · Expires 2000-08-23 · 26y expired

What this patent protects

The present invention relates to a novel process for preparing and harvesting crystalline particles, particularly particles of therapeutically useful or carrier substances of a size suitable for inhalation therapy.

USPTO Abstract

The present invention relates to a novel process for preparing and harvesting crystalline particles, particularly particles of therapeutically useful or carrier substances of a size suitable for inhalation therapy.

Drugs covered by this patent

azelastine-hydrochloride (AZELASTINE HYDROCHLORIDE)

Patent Metadata

Patent number: GB0016040D0
Jurisdiction: GB
Classification: —
Expires: 2000-08-23
Drug substance claim: No
Drug product claim: No
Assignee: Glaxo Group Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.